New Zealand markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
225.04-1.04 (-0.46%)
At close: 04:00PM EST
224.66 -0.38 (-0.17%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 118.79B
Enterprise value 143.45B
Trailing P/E 21.74
Forward P/E 11.72
PEG ratio (5-yr expected) 1.59
Price/sales (ttm)4.73
Price/book (mrq)14.46
Enterprise value/revenue 5.57
Enterprise value/EBITDA 12.99

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-9.95%
S&P500 52-week change 317.58%
52-week high 3276.69
52-week low 3198.64
50-day moving average 3217.48
200-day moving average 3228.41

Share statistics

Avg vol (3-month) 32.9M
Avg vol (10-day) 32.84M
Shares outstanding 5563.27M
Implied shares outstanding 6N/A
Float 8562.18M
% held by insiders 10.21%
% held by institutions 177.24%
Shares short (30 Dec 2021) 412.07M
Short ratio (30 Dec 2021) 43.97
Short % of float (30 Dec 2021) 42.15%
Short % of shares outstanding (30 Dec 2021) 42.14%
Shares short (prior month 29 Nov 2021) 412.94M

Dividends & splits

Forward annual dividend rate 47.76
Forward annual dividend yield 43.45%
Trailing annual dividend rate 36.88
Trailing annual dividend yield 33.04%
5-year average dividend yield 42.73
Payout ratio 470.93%
Dividend date 307 Mar 2022
Ex-dividend date 413 Feb 2022
Last split factor 22:1
Last split date 321 Nov 1999

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 21.77%
Operating margin (ttm)35.00%

Management effectiveness

Return on assets (ttm)8.70%
Return on equity (ttm)58.50%

Income statement

Revenue (ttm)25.77B
Revenue per share (ttm)44.89
Quarterly revenue growth (yoy)4.40%
Gross profit (ttm)19.27B
EBITDA 12.28B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)9.70
Quarterly earnings growth (yoy)-6.80%

Balance sheet

Total cash (mrq)12.92B
Total cash per share (mrq)22.94
Total debt (mrq)37.58B
Total debt/equity (mrq)457.33
Current ratio (mrq)1.64
Book value per share (mrq)14.54

Cash flow statement

Operating cash flow (ttm)8.61B
Levered free cash flow (ttm)7.39B